Literature DB >> 2983090

In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.

M Kohara, T Omata, A Kameda, B L Semler, H Itoh, E Wimmer, A Nomoto.   

Abstract

Infectious cDNA corresponding to the entire genome of the attenuated Sabin strain of type 1 poliovirus has been inserted into EcoRI site of bacterial plasmid pBR325. Two consecutive PstI fragments (nucleotide positions 1814 to 3421) of the infectious cDNA of the Sabin 1 strain were replaced by the corresponding DNA fragments prepared from an infectious DNA clone of the genome of the virulent Mahoney strain of poliovirus type 1. The exchanged segment encodes capsid protein VP1 and part of capsid protein VP3, a region in which a large number of amino acid differences between the attenuated Sabin and the parental, neurovirulent Mahoney strain cluster. The recombinant virus was obtained by DNA transfection of HeLa S3 cells, and several in vitro phenotypes of the virus were compared with those of the parental viruses. The recombinant virus was recognized by a neutralizing monoclonal antibody specific to the Mahoney strain. Growth of the Sabin strain of poliovirus has been shown to be quite dependent upon the bicarbonate concentration (d marker). The growth of the recombinant virus, however, was not highly dependent upon the concentration of bicarbonate in cell culture media, and thus resembled that of the Mahoney strain. On the other hand, the temperature-sensitive multiplication (rct marker) and the small-plaque morphology of the recombinant virus corresponded to the phenotype of the Sabin 1 strain. The in vitro recombination of infectious cDNA clones of genomic RNA and subsequent analysis of the growth properties of the recombinant virus have allowed us to correlate specific mutations in the genome of an RNA virus with certain biological characteristics of that virus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983090      PMCID: PMC254708     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Parameters for differentiating vaccine-derived and wild poliovirus strains.

Authors:  J H Nakano; M H Hatch; M L Thieme; B Nottay
Journal:  Prog Med Virol       Date:  1978

2.  Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region.

Authors:  A Nomoto; A Jacobson; Y F Lee; J Dunn; E Wimmer
Journal:  J Mol Biol       Date:  1979-02-25       Impact factor: 5.469

3.  Aggregation of enterovirus small plaque variants and polioviruses under low ionic strength conditions.

Authors:  A Totsuka; K Ohtaki; I Tagaya
Journal:  J Gen Virol       Date:  1978-03       Impact factor: 3.891

4.  Poliovirus single-stranded RNA and double-stranded RNA: differential infectivity in enucleate cells.

Authors:  B M Detjen; J Lucas; E Wimmer
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

5.  Mechanism of plaque inhibition of poliovirus possessing the d marker.

Authors:  C Wallis; J L Melnick
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

6.  Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals.

Authors:  B L Semler; A J Dorner; E Wimmer
Journal:  Nucleic Acids Res       Date:  1984-06-25       Impact factor: 16.971

Review 7.  Structure and expression of the picornavirus genome.

Authors:  N Kitamura; C Adler; E Wimmer
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

8.  Biochemical evidence for intertypic genetic recombination of polioviruses.

Authors:  L I Romanova; E A Tolskaya; M S Kolesnikova; V I Agol
Journal:  FEBS Lett       Date:  1980-08-25       Impact factor: 4.124

9.  Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents.

Authors:  K Wetz; K O Habermehl
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

10.  Possible point mutation sites in LSc, 2ab poliovirus RNA and a protein covalently linked to the 5'-terminus.

Authors:  A Nomoto; S Kajigaya; K Suzuki; N Imura
Journal:  J Gen Virol       Date:  1979-10       Impact factor: 3.891

View more
  33 in total

1.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.

Authors:  Cara Carthel Burns; Jing Shaw; Ray Campagnoli; Jaume Jorba; Annelet Vincent; Jacqueline Quay; Olen Kew
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.

Authors:  Judith E Mueller; Maël Bessaud; Q Sue Huang; Laura C Martinez; Patricia A Barril; Viviane Morel; Jean Balanant; Judy Bocacao; Joanne Hewitt; Brad D Gessner; Francis Delpeyroux; Silvia V Nates
Journal:  Appl Environ Microbiol       Date:  2009-01-05       Impact factor: 4.792

4.  Interaction of poliovirus with its purified receptor and conformational alteration in the virion.

Authors:  M Arita; S Koike; J Aoki; H Horie; A Nomoto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.

Authors:  C Christodoulou; F Colbere-Garapin; A Macadam; L F Taffs; S Marsden; P Minor; F Horaud
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome.

Authors:  N Iizuka; M Kohara; K Hagino-Yamagishi; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.

Authors:  N Kawamura; M Kohara; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.

Authors:  G D Westrop; K A Wareham; D M Evans; G Dunn; P D Minor; D I Magrath; F Taffs; S Marsden; M A Skinner; G C Schild
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 9.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

10.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus.

Authors:  R B Ren; E G Moss; V R Racaniello
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.